BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Business

  Teva Pharmaceutical Industries Limited Extends Agreement With Johnson & Johnson (JOBS) To Delay New Sales Of Generic Birth Control Pill Ortho Tri-Cyclen Lo

  July 20, 2009

   · 

  1 min read
• Policy

  Teva Pharmaceutical Industries Limited Provides Update on Generic Ortho Tri-Cyclen(R) Lo

  July 20, 2009

   · 

  1 min read
• Drug Development

  Orexigen Therapeutics, Inc. Schedules July 20, 2009 Teleconference and Webcast Discussion of Contrave(R) Phase 3 Results

  July 20, 2009

   · 

  1 min read
• Business

  NeurogesX, Inc. Announces Resignation of Bruce A. Peacock from Board of Directors Receives Nasdaq Notice Regarding Audit Committee Compliance

  July 20, 2009

   · 

  2 min read
• Biotech Bay

  VIA Pharmaceuticals, Inc. Receives Anticipated Notice From NASDAQ

  July 20, 2009

   · 

  2 min read
• Pharm Country

  Medrad, Inc. Recognized by the Premier Healthcare Alliance for Commitment to Healthcare Quality Improvement and Innovation

  July 20, 2009

   · 

  2 min read
• Policy

  Nycomed Announces FDA Filing for Daxas(R) in COPD

  July 20, 2009

   · 

  2 min read
• Drug Development

  Cardax Pharmaceuticals Inc. Nominates Clinical Candidate Heptax for Liver Disease; Heptax Ameliorates Inflammation and Oxidative Stress Related to Liver Disease and Metabolic Syndrome

  July 20, 2009

   · 

  2 min read
• Drug Development

  CytRx Corporation’s INNO-206 Significantly Inhibits Pancreatic Cancer Growth in Animal Trials

  July 20, 2009

   · 

  1 min read
• Bioniche Life Sciences Inc. Repays Revolving Credit Facility

  July 20, 2009

   · 

  2 min read